Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosenescence.

M S Currie1

  • 1Duke University Medical Center.

Comprehensive Therapy
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

The aging immune system shows functional decline, particularly in T-cells, increasing infection and autoimmune risks. Future biotechnology offers hope for overcoming these age-related immune changes, known as immunosenescence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons.

The journals of gerontology. Series A, Biological sciences and medical sciences·2000
Same author

Association of interleukin-6 and other biologic variables with depression in older people living in the community.

Journal of the American Geriatrics Society·1999
Same author

Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly.

The American journal of medicine·1998
Same author

The association of plasma IL-6 levels with functional disability in community-dwelling elderly.

The journals of gerontology. Series A, Biological sciences and medical sciences·1997
Same author

Tumor necrosis factor, natural killer activity and other measures of immune function and inflammation in elderly men with heart failure.

Gerontology·1995
Same author

Alterations in L-selectin expression and elastase activity in neutrophils from patients receiving granulocyte colony-stimulating factor alone or in conjunction with high-dose chemotherapy with autologous bone marrow transplantation.

Lymphokine and cytokine research·1994
Same journal

Heparin-induced thrombocytopenia and thrombosis.

Comprehensive therapy·2011
Same journal

Antiplatelet therapy in cardiovascular disease.

Comprehensive therapy·2011
Same journal

Genetics of cardiovascular disease.

Comprehensive therapy·2011
Same journal

Septic renal vein thrombosis complicated by septic pulmonary embolism.

Comprehensive therapy·2011
Same journal

Gout and hyperuricemia.

Comprehensive therapy·2011
Same journal

Problems with computerized health records.

Comprehensive therapy·2011
See all related articles

Area of Science:

  • Immunology
  • Gerontology
  • Biotechnology

Background:

  • The aging immune system exhibits subtle quantitative changes but significant functional alterations, especially in T-cell mediated immunity.
  • Age-related immune dysfunction, or immunosenescence, is linked to increased susceptibility to infections and heightened risk of autoimmune disorders.
  • The precise roles of immune system aging in degenerative and malignant diseases warrant further exploration.

Purpose of the Study:

  • To summarize the functional changes in the aging immune system.
  • To highlight the implications of immunosenescence for health and disease.
  • To discuss the potential of emerging biotechnologies in addressing age-related immune decline.

Main Methods:

  • Literature review and synthesis of current research on immunosenescence.

Related Experiment Videos

  • Analysis of functional T-cell changes in aging.
  • Overview of biotechnological approaches for immune modulation.

    • Main Results:

    • Significant functional declines in T-cells are a hallmark of immune aging.
    • Immunosenescence correlates with increased risks of infections, autoantibody production, and lymphoproliferative disorders.
    • Biotechnology advancements offer novel strategies for targeted immune system modulation.

    Conclusions:

    • Immunosenescence presents a complex challenge with implications for infectious, autoimmune, and malignant diseases.
    • Targeted biotechnological interventions hold promise for mitigating the adverse effects of immune aging.
    • Further research is crucial to fully understand and combat the multifaceted consequences of immunosenescence.